Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

Yescarta (axicabtagene ciloleucel)

Other names: anti-cluster of differentiation 19 (CD19)-CAR PBL, KTE-C19 CAR, anti-CD19 chimeric antigen receptor transduced T cells, KTEC19, KTE-C19, KTE-C19 chimeric antigen receptor T cell therapy, FKC876, FKC-876, anti-CD19-CAR PBL
Cabaret Biotech, Fosun Kite, Gilead, National Cancer Institute
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs: